# A Trial to Assess a Wearable Patch's Functioning to Detect Medication Ingestion

> **NCT06372210** · NA · COMPLETED · sponsor: **Otsuka Pharmaceutical Development & Commercialization, Inc.** · enrollment: 54 (actual)

## Conditions studied

- Mental Disorder
- Schizophrenia
- Major Depressive Disorder
- Bipolar I Disorder

## Interventions

- **DRUG:** Placebo IEM tablet
- **DRUG:** Abilify MyCite®
- **DEVICE:** D-Tect Patch

## Key facts

- **NCT ID:** NCT06372210
- **Lead sponsor:** Otsuka Pharmaceutical Development & Commercialization, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-26
- **Primary completion:** 2023-07-19
- **Final completion:** 2023-07-19
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2024-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06372210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06372210, "A Trial to Assess a Wearable Patch's Functioning to Detect Medication Ingestion". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06372210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*